High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Oncology | 2009年 / 6卷 / 1期
关键词：
D O I：
10.1038/ncponc1268
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：3 / 4
页数：1
相关论文
共 50 条
  • [1] The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine
    Ahmad, Ebtesam I.
    Gawish, Heba H.
    Al Azizi, Nashwa M. A.
    Elhefni, Ashraf M.
    [J]. ONCOTARGETS AND THERAPY, 2011, 4 : 115 - 121
  • [2] Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine:: A Cancer and Leukemia Group B study
    Neubauer, Andreas
    Maharry, Kati
    Mrozek, Krzysztof
    Thiede, Christian
    Marcucci, Guido
    Paschka, Peter
    Mayer, Robert J.
    Larson, Richard A.
    Liu, Edison T.
    Bloomfield, Clara D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4603 - 4609
  • [3] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    [J]. BLOOD, 1996, 88 (02) : 754 - 754
  • [4] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
    Lowenberg, Bob
    [J]. BLOOD, 2013, 121 (01) : 26 - 28
  • [5] Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia
    Deisseroth, Albert
    Farrell, Ann
    Justice, Robert
    Kane, Robert
    Sridhara, Rajeshwari
    Chen, Huanyu
    He, Kun
    Pazdur, Richard
    [J]. BLOOD, 2010, 115 (02) : 430 - 430
  • [6] Outcome of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Cytarabine Monotherapy
    Canaani, Jonathan
    Luskin, Marlise R.
    Loren, Alison
    Timlin, Colleen
    Mangan, James
    Hexner, Elizabeth O.
    Frey, Noelle V.
    Porter, David L.
    Stadtmauer, Edward A.
    Luger, Selina
    [J]. BLOOD, 2015, 126 (23)
  • [7] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [8] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID-LEUKEMIA
    MARCUS, RE
    CATOVSKY, D
    GOLDMAN, JM
    GALTON, DAG
    NEWLAND, AC
    SLOCOMBE, G
    HEGDE, U
    [J]. LANCET, 1985, 1 (8442): : 1384 - 1384
  • [9] INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Gil, Perez Angela
    Vazquez, Ramo Alejandro
    De Rojas, de Pablo Teresa
    Torralba, Gomez de Suso Miguel
    Nuevo, Lopez Irene
    Subira, Perez Dolores
    Merchan, Munoz Beatriz
    Perez, Ortega Alba
    De Miguel, Llorente Dunia
    [J]. HAEMATOLOGICA, 2020, 105 : 384 - 385
  • [10] High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21)
    Palmieri, S
    Sebastio, L
    Mele, G
    Annunziata, M
    Annunziata, S
    Copia, C
    Viola, A
    De Simone, M
    Pocali, B
    Schiavone, EM
    Ferrara, F
    [J]. LEUKEMIA RESEARCH, 2002, 26 (06) : 539 - 543
12345